Steve Rees is Vice-President of Screening Sciences and Sample Management at AstraZeneca with global responsibility for Compound Management, the human tissue BioBank, Hit Discovery and Lead Optimisation biology support to preclinical discovery projects.

Prior to joining AstraZeneca, Steve worked at GlaxoSmithKline for 24 years in various roles.   Steve has led multiple international collaborations, has authored more than 65 scientific papers and has spoken at many international symposia.

He is currently a member of the SLAS Europe Council and of the Board of Directors of ELRIG.  He is also a member of the Scientific Advisory Board for Medical Research Council Technology and Axol Bioscience Ltd.